Plus Therapeutics (PSTV)
3.78
-0.04 (1.05%)
Upcoming Events
Latest Headlines
Plus Therapeutics CNSide assay gains Medical Mutual coverage in Ohio
July 21, 2026 7:30 AM - StreetInsider
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
July 21, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics and Genomic Testing Cooperative to expand CSF platform
July 16, 2026 7:31 AM - StreetInsider
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
July 16, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics highlights CNSide role after NCCN guideline update
July 14, 2026 7:32 AM - StreetInsider
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
July 14, 2026 7:30 AM - Globe NewsWire
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: van Es-Johansson An
July 1, 2026 4:31 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: HEDRICK MARC H
July 1, 2026 4:31 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: Guse Kyle
July 1, 2026 4:31 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: ANDREWS RONALD ASBURY
July 1, 2026 4:31 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: Clowes Howard
July 1, 2026 4:31 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: Hawkins Richard J
July 1, 2026 4:30 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: Jul 01 Filed by: Sims Andrew John Hugh MacIntyre
July 1, 2026 4:30 PM - SEC Filing
Plus Therapeutics to rebrand as Cerenome, trade as CNSY on Aug. 3
June 30, 2026 7:31 AM - StreetInsider
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics unit signs national coverage deal with Elevance Health
June 25, 2026 7:31 AM - StreetInsider
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics to Provide Business Update Call on June 30, 2026
June 23, 2026 7:30 AM - Globe NewsWire
Form S-8 PLUS THERAPEUTICS, INC.
June 18, 2026 4:31 PM - SEC Filing
Form EFFECT PLUS THERAPEUTICS, INC.
June 8, 2026 6:03 AM - SEC Filing
Form 8-K PLUS THERAPEUTICS, INC. For: Jun 01
June 5, 2026 4:31 PM - SEC Filing
Form S-3/A PLUS THERAPEUTICS, INC.
June 5, 2026 7:31 AM - SEC Filing
CNSide Diagnostics receives CAP laboratory accreditation
June 4, 2026 7:30 AM - StreetInsider
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
June 4, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics (PSTV) files $100M mixed shelf
June 2, 2026 6:10 AM - StreetInsider
Form S-3 PLUS THERAPEUTICS, INC.
June 2, 2026 6:08 AM - SEC Filing
Plus CNSide diagnostic shows potential 40% healthcare cost reduction
May 26, 2026 7:32 AM - StreetInsider
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
May 26, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics partners with Ephemeral Technologies for AI platform
May 19, 2026 7:30 AM - StreetInsider
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
May 19, 2026 7:30 AM - Globe NewsWire
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: van Es-Johansson An
May 18, 2026 4:21 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: Hawkins Richard J
May 18, 2026 4:18 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: Guse Kyle
May 18, 2026 4:18 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: Clowes Howard
May 18, 2026 4:16 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: ANDREWS RONALD ASBURY
May 18, 2026 4:15 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: Sims Andrew John Hugh MacIntyre
May 18, 2026 4:14 PM - SEC Filing
Form 4 PLUS THERAPEUTICS, INC. For: May 14 Filed by: HEDRICK MARC H
May 18, 2026 4:12 PM - SEC Filing
Form 8-K PLUS THERAPEUTICS, INC. For: May 14
May 15, 2026 4:47 PM - SEC Filing
Form 10-Q PLUS THERAPEUTICS, INC. For: Mar 31
May 15, 2026 4:39 PM - SEC Filing
Form 8-K PLUS THERAPEUTICS, INC. For: May 15
May 15, 2026 4:18 PM - SEC Filing
Plus Therapeutics reports Q1 2026 results, adds coverage for 81 million
May 15, 2026 4:05 PM - StreetInsider
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
May 15, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13G/A PLUS THERAPEUTICS, INC. Filed by: CVI Investments, Inc.
May 15, 2026 12:21 PM - SEC Filing
Form SCHEDULE 13G PLUS THERAPEUTICS, INC. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
May 15, 2026 6:46 AM - SEC Filing
Plus Therapeutics presents REYOBIQ data at neurosurgery meeting
May 8, 2026 7:30 AM - StreetInsider
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastas
May 8, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics subsidiary gets Medicare enrollment for diagnostic test
May 7, 2026 7:30 AM - StreetInsider
Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
May 7, 2026 7:30 AM - Globe NewsWire
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
April 28, 2026 7:30 AM - Globe NewsWire
Full Article List
